140 related articles for article (PubMed ID: 34560656)
41. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
42. A novel MRI-based score assessing trabecular bone quality to predict vertebral compression fractures in patients with spinal metastasis.
Ehresman J; Schilling A; Pennington Z; Gui C; Chen X; Lubelski D; Ahmed AK; Cottrill E; Khan M; Redmond KJ; Sciubba DM
J Neurosurg Spine; 2019 Dec; 32(4):499-506. PubMed ID: 31860825
[TBL] [Abstract][Full Text] [Related]
43. Incidence and Prognostic Factors of Painful Vertebral Compression Fracture Caused by Spine Stereotactic Body Radiotherapy.
Ito K; Taguchi K; Nakajima Y; Ogawa H; Sugita S; Murofushi KN
J Clin Med; 2023 Jun; 12(11):. PubMed ID: 37298048
[TBL] [Abstract][Full Text] [Related]
44. Can the spinal instability neoplastic score prior to spinal radiosurgery predict compression fractures following stereotactic spinal radiosurgery for metastatic spinal tumor?: a post hoc analysis of prospective phase II single-institution trials.
Lee SH; Tatsui CE; Ghia AJ; Amini B; Li J; Zavarella SM; Tannir NM; Brown PD; Rhines LD
J Neurooncol; 2016 Feb; 126(3):509-17. PubMed ID: 26643804
[TBL] [Abstract][Full Text] [Related]
45. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
[TBL] [Abstract][Full Text] [Related]
46. T2-weighted imaging-based radiomic-clinical machine learning model for predicting the differentiation of colorectal adenocarcinoma.
Zheng HD; Huang QY; Huang QM; Ke XT; Ye K; Lin S; Xu JH
World J Gastrointest Oncol; 2024 Mar; 16(3):819-832. PubMed ID: 38577440
[TBL] [Abstract][Full Text] [Related]
47. Developing a clinical-radiomic prediction model for 3-year cancer-specific survival in lung cancer patients treated with stereotactic body radiation therapy.
Huang BT; Wang Y; Lin PX
J Cancer Res Clin Oncol; 2024 Jan; 150(2):34. PubMed ID: 38277078
[TBL] [Abstract][Full Text] [Related]
48. Multi-institutional dose-segmented dosiomic analysis for predicting radiation pneumonitis after lung stereotactic body radiation therapy.
Adachi T; Nakamura M; Shintani T; Mitsuyoshi T; Kakino R; Ogata T; Ono T; Tanabe H; Kokubo M; Sakamoto T; Matsuo Y; Mizowaki T
Med Phys; 2021 Apr; 48(4):1781-1791. PubMed ID: 33576510
[TBL] [Abstract][Full Text] [Related]
49. Radiomic Modeling of Bone Density and Rib Fracture Risk After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
Rydzewski NR; Yadav P; Musunuru HB; Condit KM; Francis D; Zhao SG; Baschnagel AM
Adv Radiat Oncol; 2022; 7(3):100884. PubMed ID: 35647405
[TBL] [Abstract][Full Text] [Related]
50. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma.
Chang C; Sun X; Wang G; Yu H; Zhao W; Ge Y; Duan S; Qian X; Wang R; Lei B; Wang L; Liu L; Ruan M; Yan H; Liu C; Chen J; Xie W
Front Oncol; 2021; 11():603882. PubMed ID: 33738250
[TBL] [Abstract][Full Text] [Related]
51. Develop a radiomics-based machine learning model to predict the stone-free rate post-percutaneous nephrolithotomy.
Zou XC; Luo CW; Yuan RM; Jin MN; Zeng T; Chao HC
Urolithiasis; 2024 Apr; 52(1):64. PubMed ID: 38613668
[TBL] [Abstract][Full Text] [Related]
52. Combining computed tomography and biologically effective dose in radiomics and deep learning improves prediction of tumor response to robotic lung stereotactic body radiation therapy.
Avanzo M; Gagliardi V; Stancanello J; Blanck O; Pirrone G; El Naqa I; Revelant A; Sartor G
Med Phys; 2021 Oct; 48(10):6257-6269. PubMed ID: 34415574
[TBL] [Abstract][Full Text] [Related]
53. Clinical-MRI radiomics enables the prediction of preoperative cerebral spinal fluid dissemination in children with medulloblastoma.
Zheng H; Li J; Liu H; Wu C; Gui T; Liu M; Zhang Y; Duan S; Li Y; Wang D
World J Surg Oncol; 2021 Apr; 19(1):134. PubMed ID: 33888125
[TBL] [Abstract][Full Text] [Related]
54. Differentiation of acute and chronic vertebral compression fractures using conventional CT based on deep transfer learning features and hand-crafted radiomics features.
Zhang J; Liu J; Liang Z; Xia L; Zhang W; Xing Y; Zhang X; Tang G
BMC Musculoskelet Disord; 2023 Mar; 24(1):165. PubMed ID: 36879285
[TBL] [Abstract][Full Text] [Related]
55. Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases.
Sahgal A; Whyne CM; Ma L; Larson DA; Fehlings MG
Lancet Oncol; 2013 Jul; 14(8):e310-20. PubMed ID: 23816297
[TBL] [Abstract][Full Text] [Related]
56. Predicting the need for a replan in oropharyngeal cancer: A radiomic, clinical, and dosimetric model.
Chinnery TA; Lang P; Nichols AC; Mattonen SA
Med Phys; 2024 May; 51(5):3510-3520. PubMed ID: 38100260
[TBL] [Abstract][Full Text] [Related]
57. Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy.
Moran A; Daly ME; Yip SSF; Yamamoto T
Clin Lung Cancer; 2017 Nov; 18(6):e425-e431. PubMed ID: 28623121
[TBL] [Abstract][Full Text] [Related]
58. Radiomic Analysis of Positron-Emission Tomography and Computed Tomography Images to Differentiate between Multiple Myeloma and Skeletal Metastases.
Mannam P; Murali A; Gokulakrishnan P; Venkatachalapathy E; Venkata Sai PM
Indian J Nucl Med; 2022; 37(3):217-226. PubMed ID: 36686312
[TBL] [Abstract][Full Text] [Related]
59. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
Zeng KL; Abugarib A; Soliman H; Myrehaug S; Husain ZA; Detsky J; Ruschin M; Karotki A; Atenafu EG; Larouche J; Campbell M; Maralani P; Sahgal A; Tseng CL
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):686-695. PubMed ID: 36309076
[TBL] [Abstract][Full Text] [Related]
60. Development of a multi-feature-combined model: proof-of-concept with application to local failure prediction of post-SBRT or surgery early-stage NSCLC patients.
Yang Z; Wang C; Wang Y; Lafata KJ; Zhang H; Ackerson BG; Kelsey C; Tong B; Yin FF
Front Oncol; 2023; 13():1185771. PubMed ID: 37781201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
